Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 1.789 Q1 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | 36.86 | |
2 | Current Gene Therapy | journal | 1.565 Q1 | 80 | 45 | 141 | 5121 | 693 | 127 | 5.30 | 113.80 | 43.02 | |
3 | Current Molecular Pharmacology | journal | 1.560 Q1 | 49 | 39 | 59 | 3998 | 291 | 57 | 4.38 | 102.51 | 40.00 | |
4 | Current Medicinal Chemistry | journal | 1.538 Q2 | 202 | 504 | 1001 | 59089 | 5168 | 970 | 4.57 | 117.24 | 39.58 | |
5 | Current Protein and Peptide Science | journal | 1.339 Q2 | 96 | 74 | 204 | 8257 | 600 | 179 | 2.23 | 111.58 | 43.38 | |
6 | Current Drug Targets | journal | 1.332 Q1 | 119 | 194 | 483 | 18772 | 1881 | 438 | 4.21 | 96.76 | 34.09 | |
7 | Current Genomics | journal | 1.273 Q2 | 77 | 67 | 184 | 5787 | 595 | 175 | 3.01 | 86.37 | 35.09 | |
8 | Current Organic Synthesis | journal | 1.102 Q2 | 55 | 53 | 110 | 5470 | 284 | 101 | 1.94 | 103.21 | 33.33 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q2 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | 41.41 | |
10 | Current Diabetes Reviews | journal | 1.034 Q2 | 68 | 49 | 129 | 5136 | 460 | 127 | 3.24 | 104.82 | 34.59 | |
11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 108 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | 40.32 | |
12 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | 35.18 | |
13 | Current Computer-Aided Drug Design | journal | 0.510 Q3 | 32 | 29 | 76 | 1626 | 134 | 70 | 1.80 | 56.07 | 26.76 | |
14 | Current Nanoscience | journal | 0.453 Q2 | 52 | 135 | 296 | 4918 | 504 | 292 | 1.52 | 36.43 | 34.61 | |
15 | Current Pharmaceutical Analysis | journal | 0.425 Q3 | 27 | 48 | 96 | 1591 | 147 | 95 | 1.50 | 33.15 | 43.26 | |
16 | Letters in Organic Chemistry | journal | 0.301 Q3 | 33 | 132 | 403 | 3683 | 295 | 402 | 0.68 | 27.90 | 32.45 | |
17 | Current Proteomics | journal | 0.296 Q3 | 27 | 24 | 90 | 2070 | 189 | 83 | 0.81 | 86.25 | 39.33 | |
18 | Letters in Drug Design and Discovery | journal | 0.284 Q4 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | 39.89 | |
19 | Current Bioinformatics | journal | 0.238 Q4 | 38 | 53 | 87 | 3834 | 180 | 84 | 2.19 | 72.34 | 30.00 | |
20 | Current Cancer Therapy Reviews | journal | 0.226 Q4 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | 35.37 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®